Results 121 to 130 of about 21,293 (203)

The efficacy and safety of doravirine/lamivudine/tenofovir disoproxil fumarate in treatment-naïve and treatment-experienced patients with HIV. [PDF]

Ann Med
Yang H, Li M, Liu Q, Zeng Q, Yuan J.
europepmc   +1 more source

Bone Changes With Long-Acting Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention in Cisgender Men and Transgender Women: HPTN 083. [PDF]

Clin Infect Dis
Brown TT, Arao RF, Warsi M, Phanuphak N, Vasconcelos R, Oyedele T, Sullivan PA, Hanscom B, Rooney JF, Rinehart AR, McCauley M, Grinsztejn B, Landovitz RJ.   +12 more
europepmc   +1 more source

Review Article: Renal Safety Profiles of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, and Entecavir for the Treatment of Chronic Hepatitis B Infection-General and Special Populations. [PDF]

Aliment Pharmacol Ther
Mak LY, Hu TH, Yap DYH.
europepmc   +1 more source

Early experience of dolutegravir pharmacokinetics in pregnancy: high maternal levels and significant foetal exposure with twice-daily dosing [PDF]

, 2016
Chaponda, Mas, Khoo, Saye, Lewis, Joseph M, Railton, Eimear, Riordan, Andrew   +4 more
core   +1 more source

Comparable efficacy of bictegravir/emtricitabine/tenofovir alafenamide and doravirine/lamivudine/tenofovir disoproxil fumarate in therapy-naive Human Immunodeficiency Virus adults with very high baseline viraemia. [PDF]

J Med Microbiol
Calza L, Giglia M, Rigamonti C, Zuppiroli A, Marzolla D, Bon I, Viale P.   +6 more
europepmc   +1 more source

Assessment of the risk of discontinuation of tenofovir disoproxil fumarate after delivery and the benefit of continued treatment in patients with immune tolerance. [PDF]

Front Med (Lausanne)
Liang H, Liang H, Hu B, Huang L, Liang H, Su M, Wang R, Su T, Li Q, Feng Y, Jiang J.   +10 more
europepmc   +1 more source

A retrospective comparative study of tenofovir alafenamide and tenofovir disoproxil fumarate in chronic hepatitis B patients: Renal and bone safety versus antiviral efficacy. [PDF]

Medicine (Baltimore)
Wang L, Pi G, Lu D, Wang Y, Sun W.
europepmc   +1 more source

A National Multicenter Study on Initial Antiviral Treatment Preferences on Chronic Hepatitis B: Entecavir Versus Tenofovir Disoproxil Fumarate. [PDF]

Turk J Gastroenterol
Yamazhan T, Zerdali E, Önlen Y, Tosun S, Günal Ö, Batırel A, Hasanoğlu İ, Turunç T, Balcı U, Kaya SY, Karabay O, Yıldız İE, Altunal LN, Özkaya HD, Kaya S, İnci A, Alkan S, Yıldız DS, Bal T, Aydemir EA, Eser N, Uysal S, Acet O, Tabak F, Güner R.   +24 more
europepmc   +1 more source

Comparative Renal Safety of Besifovir Dipivoxil Maleate and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients: Insights From a Nationwide Cohort Study. [PDF]

J Korean Med Sci
Choi HB, Kim JY, Yoo JJ, Kim SG, Kim YS.
europepmc   +1 more source

Efficacy and safety of bictegravir, emtricitabine, and tenofovir alafenamide (BIC/FTC/TAF) versus efavirenz, lamivudine, and tenofovir disoproxil fumarate (EFV+3TC + TDF) in late-presenting people with HIV rapid initial antiretroviral therapy. [PDF]

BMC Infect Dis
Li Q, Li J, Gao C, Zhao Y, Zhu L, Xiao J, Zhang F.   +6 more
europepmc   +1 more source